Renal cancer falls into the category of relatively rare cancers. Worldwide there were 208,500 patients diagnosed in 2006, accounting for just under 2% of all cancers. Tumours within the kidney have been found in any age group but are most common in people over the age of 55, and they are more common in men than in women with a ratio of 5:3. The highest rates of renal cancer are in the USA and the lowest are in Asia and Africa.
Cancers of the kidney can result from the malignant transformation of the urothelium (lining of the collecting system) or of the renal substance (parenchyma) itself. This course will only focus on the management of carcinomas of the renal parenchyma – renal cancer. Note: the term renal cancer and kidney cancer are used interchangeably throughout the course.
The overall 5-year survival rate for renal cancer is nearly 60%, but is very dependant on the stage at diagnosis and the histological grade. With the recent advances in the drug treatment of renal cancer many patients with metastatic disease will survive longer meaning more nurses will be coming into contact with these patients. It is therefore essential that nurses have knowledge of the disease and the treatments in order to provide a high standard of quality care for this group of patients.
On completion of this course, learners will be able to:
This course has been written by a team from the United Kingdom:
- Debbie Victor RGN BSc(Hons) PGCE, Uro-Oncology Clinical Nurse Specialist, Royal Cornwall Hospital.
- Sharon Deveson Kell BSc PhD MBA, Medical Publications Officer, James Whale Fund for Kidney Cancer.
- Lucy Powell RGN DipHE MSc, Uro-oncology Clinical Nurse Specialist, Colchester Hospital University Foundation Trust.
- Angie Wilcox RGN BSc(Hons), Macmillan Urology Clinical Nurse Specialist, Barking, Havering and Redbridge Hospitals NHS Trust.
Prior to launch the course was reviewed by:
- Hilary Baker, Macmillan Uro-Oncology Clinical Nurse Specialist, Buckinghamshire Hospitals NHS Trust, High Wycombe, UK.
- Krystyna Caine, Macmillan Uro-Oncology Clinical Nurse Specialist, Buckinghamshire Hospitals NHS Trust, High Wycombe, UK.
- Richard Coulthard, Consultant Urological Surgeon, Cardiff and Vale UHB, Cardiff, UK.
- Charlotte Etheridge, Macmillan Urology Nurse Specialist, Ipswich Hospital NHS Trust, Ipswich, UK.
- Jane Gosling, Nurse Consultant - Urology, Derriford Hospital, Plymouth, UK.
- Joyleen Mathew, Assistant Nursing Superintendent, Ruby Hall Clinic, Pune, India.
- Hazel McBain, Urology Surgery Research Nurse Specialist, Cancer Clinical Trials Unit, University College London Hospital NHS Trust, London, UK.
- Carol Popplestone, Macmillan Clinical Nurse Specialist (Uro-Oncology), Scarborough and North East Yorkshire Health Care NHS Trust, Scarborough Hospital, Scarborough, UK.
- Alayne Reid, Nurse Educator, Division of Cancer Services, Mater Health Services, South Brisbane, Australia.
- Patricia Russell, Registered Nurse, Radiology Nursing Team, Radiology Department, Hawke's Bay District Health Board, Hawke’s Bay, New Zealand.
- Julie Sykes, Urology Cancer Nurse Coordinator, Western Australia Cancer and Palliative Care Network, Perth, Australia.
- Nikolai Yordanov, Head Palliative Care Department, Interregional Cancer Hospital - "Vratsa", Vratsa , Bulgaria.
Further information on CancerNursing.org's online courses can be found on the frequently-asked questions page.